Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LogixX Fertility is a specialty pharmaceutical and medical marketing company based in the United Kingdom, dedicated to providing evidence-based solutions for reproductive health. The company focuses on addressing the underlying causes of infertility, such as oxidative stress and sperm DNA fragmentation, through a portfolio of specialized nutraceuticals and diagnostic tools. Their flagship products, including Condensyl and Fertilix, are designed to optimize gamete quality and improve clinical outcomes for couples undergoing assisted reproductive technology (ART) or attempting natural conception. LogixX Fertility collaborates closely with fertility clinics and healthcare professionals to integrate nutritional therapy into standard fertility care protocols. The company is a division of LogixX Pharma, leveraging expertise in pharmaceutical development to ensure high standards of product efficacy and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LogixX Fertility.